迪哲医药-U
(688192)
| 流通市值：257.22亿 | | | 总市值：259.42亿 |
| 流通股本：4.61亿 | | | 总股本：4.65亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 4,769,564,247.74 | 522,692,723.71 | 252,521,933.82 | 801,135,558.29 |
| 营业总成本 | 1,166,484,139.04 | 759,304,599.27 | 365,009,076.26 | 1,654,178,465.58 |
| 其他经营收益 | | | | |
| 营业利润 | 3,634,519,915.94 | -212,624,705.97 | -96,366,424.2 | -766,362,723.31 |
| 利润总额 | 3,634,683,506.13 | -212,462,244.08 | -96,342,303.81 | -767,126,713.42 |
| 净利润 | 3,634,289,248.01 | -213,095,536.85 | -96,702,205.01 | -768,517,444.68 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 3,634,289,248.01 | -213,095,536.85 | -96,702,205.01 | -768,517,444.68 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 5,879,505,763.45 | 2,057,299,920.68 | 2,206,328,946.16 | 2,182,677,146.71 |
| 非流动资产: | | | | |
| 非流动资产合计 | 771,149,813.52 | 790,563,074.4 | 806,690,760.82 | 819,852,041.7 |
| 资产总计 | 6,650,655,576.97 | 2,847,862,995.08 | 3,013,019,706.98 | 3,002,529,188.41 |
| 流动负债: | | | | |
| 流动负债合计 | 883,056,219.39 | 783,193,982.93 | 782,358,538.05 | 985,234,095.28 |
| 非流动负债: | | | | |
| 非流动负债合计 | 786,100,895.86 | 935,548,717.67 | 995,480,353.85 | 721,604,244.62 |
| 负债合计 | 1,669,157,115.25 | 1,718,742,700.6 | 1,777,838,891.9 | 1,706,838,339.9 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,984,151,386.75 | 1,130,009,315.98 | 1,234,492,519.32 | 1,293,857,703.25 |
| 股东权益合计 | 4,981,498,461.72 | 1,129,120,294.48 | 1,235,180,815.08 | 1,295,690,848.51 |
| 负债和股东权益合计 | 6,650,655,576.97 | 2,847,862,995.08 | 3,013,019,706.98 | 3,002,529,188.41 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,907,403,126.55 | 539,177,353 | 269,066,184.94 | 846,127,427.66 |
| 经营活动现金流出小计 | 1,258,048,827.28 | 813,485,135.28 | 469,543,816.09 | 1,434,452,216.23 |
| 经营活动产生的现金流量净额 | 3,649,354,299.27 | -274,307,782.28 | -200,477,631.15 | -588,324,788.57 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,346,520,204.08 | 3,643,536,245.91 | 1,896,479,023.2 | 9,968,760,226.68 |
| 投资活动现金流出小计 | 5,106,664,891.27 | 3,588,297,105.89 | 1,989,913,521.14 | 11,167,469,026.06 |
| 投资活动产生的现金流量净额 | 239,855,312.81 | 55,239,140.02 | -93,434,497.94 | -1,198,708,799.38 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 472,508,080.53 | 472,508,080.53 | 425,308,080.53 | 2,604,143,496.05 |
| 筹资活动现金流出小计 | 435,655,537.65 | 365,456,824.56 | 198,961,877.8 | 775,458,604.24 |
| 筹资活动产生的现金流量净额 | 36,852,542.88 | 107,051,255.97 | 226,346,202.73 | 1,828,684,891.81 |
| 汇率变动对现金及现金等价物的影响 | -3,932,338.91 | -265,176.13 | -158,619.01 | -394,408.41 |
| 现金及现金等价物净增加额 | 3,922,129,816.05 | -112,282,562.42 | -67,724,545.37 | 41,256,895.45 |
| 期末现金及现金等价物余额 | 4,213,276,454.13 | 178,864,075.66 | 223,422,092.71 | 291,146,638.08 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -112,282,562.42 | - | 41,256,895.45 |
最新报告期：2026-09-07| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东海证券 | 杜永宏 | -0.96 | 0.17 | 1.03 | 2026-09-07 |
| 浙商证券 | 盖文化,郭双喜 | 6.77 | 1.36 | 1.69 | 2026-08-22 |
| 中金公司 | 张琎,刘雅馨,朱言音 | 6.43 | 0.66 | -- | 2026-08-22 |
| 东吴证券 | 朱国广 | 7.66 | 0.23 | 1.25 | 2026-08-21 |